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ABSTRACT: A methyl group on an arene, despite its small
size, can have a profound inﬂuence on biologically active
molecules. Typical methods to form a methylarene involve
strong nucleophiles or strong and often toxic electrophiles. We
report a strategy for a new, highly eﬃcient, copper and iodide
co-catalyzed methylation of aryl- and heteroarylboronic esters
with the mild, nontoxic reagent trimethylphosphate, which has
not been used previously in coupling reactions. We show that
it reacts in all cases tested in yields that are higher than those
of analogous copper-catalyzed reactions of MeOTs or MeI.
The combination of C−H borylation and this methylation
with trimethylphosphate provides a new approach to the
functionalization of inert C−H bonds and is illustrated by late-stage methylation of four medicinally active compounds. In
addition, reaction on a 200 mmol scale demonstrates reliability of this method. Mechanistic studies show that the reaction
occurs by a slow release of methyl iodide by reaction of PO(OMe)3 with iodide catalyst, rather than the typical direct oxidative
addition to a metal center. The low concentration of the reactive electrophile enables selective reaction with an arylcopper
intermediate, rather than nucleophilic groups on the arylboronate, and binding of tert-butoxide to the boronate inhibits reaction
of the electrophile with the tert-butoxide activator to form methyl ether.
■ INTRODUCTION
A methyl group is the smallest nonpolar substituent in organic
chemistry and is inert toward most organic transformations.
Many studies have shown that a methyl group modulates the
solubility, hydrophilicity, and conformation of a drug, thus
leading to the term “magic methyl eﬀect”.1 In addition,
isotopically labeled methyl groups are important for medicinal
chemistry. For example, Austedo, an FDA-approved drug for
the treatment of chorea, contains a deuterated methyl group to
attenuate the drug metabolism and improve tolerability by
reducing adverse events related to peak plasma concentra-
tions.2 Attesting to this profound eﬀect of a methyl group, a
survey by Njardarson showed that over 67% of the top 200
selling small-molecule drugs in 2011 contained at least one
methyl group.1c Hence, eﬃcient methods for selective
installation of methyl groups, particularly installation at the
position of a C−H bond, are highly desirable.3
Arylboronic acids are versatile reagents and can be accessed
by numerous synthetic methodologies.4 Direct methylation of
arylboronic acids or derivatives of them would be a convenient
method to introduce a methyl group into widely existing
aromatic structures in biologically active molecules. However,
reports of methods to couple arylboronic acids or esters with a
methyl electrophile are scarce.5 In 2004, Gooßen developed a
Pd-catalyzed cross-coupling reaction of ArB(OH)2 with MeI as
the methyl electrophile.5a More recently, Liu reported the
methylation of two arylboronic neopentanediolate esters
(ArBneop) with MeOTs as the electrophile in the presence
of a Cu catalyst.5b In both cases, the substrate scope is limited.
Because MeI and MeOTs are highly reactive methyl
electrophiles, it is possible that substrates containing basic
functional groups or heteroaryl groups would undergo
uncatalyzed methylation to form undesired side products.
A reliable method for the methylation of arylboronic esters
with broad scope could be valuable for many applications,
particularly the overall conversion of an aryl or heteroaryl C−
H bond to the corresponding aryl- or heteroarylmethane
(Scheme 1). However, to be applicable for such processes, the
reaction must meet several requirements. First, the methylation
process must occur with pinacol-substituted aryl- and hetero-
arylboronates, because this class of arylboronates is formed by
the borylation of C−H bonds.6 Second, a higher tolerance for
basic and heteroaryl moieties must be realized than that of
reactions of aryl- and heteroarylboronates with MeI or
MeOTs. Presumably, this higher tolerance would require a
milder source of methyl electrophile than has been used
previously for the coupling with arylboronates. Finally, for the
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most practical applications, a methyl electrophile should be
used that is inexpensive, available on large scale, and less
mutagenic than the standard highly reactive methyl halides,
sulfates, and sulfonates.7
We report the copper and iodide co-catalyzed methylation of
a wide range of aryl and heteroaryl pinacolboronates with
trimethylphosphate as a new methylating agent in coupling
reactions.8 Detailed mechanistic analysis of the process shows
that the phosphate does not react directly with the copper
catalyst. Instead, the conditions developed lead to a slow
release of MeI that reacts rapidly with an arylcopper species.
By this slow-release mechanism, the reaction occurs with a
wide range of both aryl- and heteroarylboronates in yields that
are much higher than those obtained with the analogous
copper-catalyzed reactions with MeI, MeOTs, or Me2SO4.
Studies on the combined borylation and methylation of
medicinally active compounds show that this process is
suitable for the site-selective methylation of biologically active
compounds, and reactions on 200 mmol of arylboronate show
that this methylation process should be suitable for process
scale.
■ RESULTS AND DISCUSSION
Reaction Development. To develop the methylation of
aryl pinacolboronates, we studied the reactions of 1-naphthyl-
Bpin (1a) as the model substrate, in part because of the high
boiling point of the product and ability to detect the
protodeboronation product. A series of experiments showed
(see Supporting Information (SI) for details) that the
methylated product 2a was obtained in 93% yield with a
copper catalyst, iodide co-catalyst, LiOtBu as the base, and
PO(OMe)3 as the source of methyl group in DMI solvent at
50 °C (Table 1, standard condition).
The series of experiments shown in Table 1 reveal the
importance of each component. Conventional methylation
reagents, like MeI, MeOTs, Me2SO4, and CO(OMe)2 reacted
in much lower yield (Table 1, entry 2−5, 0−54% vs 93%).
Reactions in the absence of CuI formed no methylated product
(entry 6). The presence of iodide in the system seemed crucial
for obtaining high yields. Reactions with copper catalysts
lacking iodide occurred in much lower yield than those
catalyzed by CuI, and reactions catalyzed by CuI with added
LiI occurred in a much higher yield (entry 1, 93%) than those
in the absence of LiI (entry 7, 29%). Because the reactions
with and without LiI also contain LiOtBu, the iodide in the LiI
is important. To exclude the potential requirement that the
reaction requires CuI, other types of copper sources were
tested. In the absence of an added catalytic amount of LiI,
CuBr·Me2S was the only complex of ﬁve tested that gave
product, and this catalyst gave the product in a low 36% yield;
none of the reactions catalyzed by CuOAc, CuCl, CuTc, or
Cu(MeCN)4PF6 gave methylated product 2a (entry 8).
However, product 2a was observed in over 60% yield from
reactions initiated with all of these catalyst precursors when the
reactions contained 20 mol% of LiI (entry 9). The precise role
of each of the reaction components was elucidated by
mechanistic studies described in the ﬁnal section of this paper.
Scope of Arylboronic Esters That Undergo Methyl-
ation with PO(OMe)3. The scope of the methylation of a
group of arylboronic esters with PO(OMe)3 was assessed, and
the results are summarized in Scheme 2. Electron-withdrawing
substituents, such as Cl, Br, and I, were well tolerated,
aﬀording the corresponding methylarene in 70−85% yield
(2b−2d). These reactions occur without any interference from
the halides or reaction between the boronate unit and a halide.
Arylboronic esters containing electron-donating groups (1e,
1h) also were suitable for the methylation with PO(OMe)3,
providing products 2e and 2h in 69% and 58% yield,
respectively. Reaction of the electron-rich ferrocenylboronate
1i aﬀorded the methylated product 2i in 79% yield. An ortho-
substituent did not inhibit the process; rather product 2g
formed in a high 97% yield. Substrates containing ester, amide,
or OTBS functionality also underwent methylation, in this case
to form 2f, 2j, and 2k in 68−76% yield. Finally, the
methylation process was applied to complex molecules 1l
and 1m; the methylation of these compounds occurred in 71%
and 68% yield, respectively.
To assess whether PO(OMe)3 was a more eﬀective agent for
methylation than more commonly used MeOTs or MeI, we
tested these reactions with the copper catalyst and alkoxide
activator with these two reagents. These data are included in
Scheme 2. These data show that methylation of each substrate
occurred in higher yield with PO(OMe)3 than with MeI or
MeOTs. For example, product 2b was obtained in 85%, 33%,
and 10% yield from the copper-catalyzed reactions with
PO(OMe)3, MeOTs, and MeI, respectively. Likewise, the
simple 2-methylbiphenyl product 2g formed in 97% yield with
PO(OMe)3 but only 33% yield with MeOTs and 27% yield
with MeI. For all of the cases in Scheme 2, the advantage of
using PO(OMe)3 was obvious for increasing the reaction
eﬃciency.
Scheme 1. Research Design Table 1. Standard Reaction Conditions and Control
Experiments
entry variation from the standard conditions yielda (%)
1 none 93b
2 MeI instead of PO(OMe)3 24
3 MeOTs instead of PO(OMe)3 54
4 Me2SO4 instead of PO(OMe)3 23
5 CO(OMe)2 instead of PO(OMe)3 n.d.
6 without CuI n.d.
7 without LiI 29
8 other [Cu] sources instead of CuI, no LiI 0−36
9 other [Cu] sources instead of CuI, with LiI 61−85
[Cu]
CuOAc CuCl CuBr·Me2S CuTc Cu(MeCN)4PF6
no LiI n.d. trace 36% n.d. n.d.
with LiI 61% 70% 85% 75% 75%
aDetermined by crude 1H NMR spectroscopy with CH2Br2 as the
internal standard. bIsolated yield. DMI = 1,3-dimethyl-2-imidazol-
idinone; n.d. = not detected.
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Scope of Heteroarylboronic Esters That Undergo
Methylation with PO(OMe)3. Heteroaromatic moieties are
ubiquitous in biologically active molecules, but cross-couplings
of heteroarenes are usually more challenging to achieve than
those with less polar and less basic arenes. Substrates
containing a basic nitrogen could be a particular challenge
for reactions with an electrophilic methyl group, due to the
potential of uncatalyzed methylation of the basic nitrogen
atom and the potential to sequester the unligated copper
catalyst.
Nevertheless, the results in Scheme 3 showed that the
methylation occurred with a broad range of heteroaryl
pinacolboronic esters. Nitrogen-containing heterocycles like
indole, pyrazole, pyrimidine, and carbazole were well tolerated
and produced the corresponding methylated heteroarenes in
62−90% yield (4a−4e, 4g). A sterically hindered pyridine 3h
aﬀorded 4h in moderate yield. Reaction of the heteroaryl-
boronates, which contain oxygen and sulfur heterocycles (3f,
3j−3l, 3m, 3o), gave the corresponding methyl-heteroarenes
in 78−99% yield. Likewise, reactions of benzoxazole and
benzothiazole (3i, 3n), as representative heteroarenes
containing multiple heteroatoms, aﬀorded the corresponding
methyl-heteroarenes 4i and 4n in 96% and 67% yield,
respectively. Due to the value of labeled methyl groups in
the medicinal ﬁeld, the reactions of 3d and 3m with
commercially available PO(OCD3)3 were also tested, giving
d3-4d and d3-4m in high isolated yields (75% and 89%,
respectively).
As we did for the copper-catalyzed methylation of arenes, we
tested the copper-catalyzed methylation of heteroarenes with
MeOTs and MeI as methylating agents. Again, the yields were
uniformly higher for reactions with trimethylphosphate than
for those with MeOTs or MeI. For example, indole 3a reacted
with PO(OMe)3 in 62% yield while it reacted with both
MeOTs and MeI in less than 5% yield; For other substrates,
Scheme 2. Scope of Arylboronic Esters That Undergo
Methylation with PO(OMe)3
a
aConditions: 1 (1.0 equiv), PO(OMe)3 (1.1 equiv), CuI (5−10 mol
%), LiI (20 mol%), LiOtBu (1.1 equiv), DMI (0.66M), 50 °C.
Isolated yields are reported. For cases of MeOTs and MeI, yields were
determined by crude 1H NMR or 19F NMR. bDetermined by crude
1H NMR.
Scheme 3. Scope of Heteroarylboronic Esters That Undergo
Methylation with PO(OMe)3
a
aConditions: 3 (1.0 equiv), PO(OMe)3 (1.1 equiv), CuI (10 mol%),
LiI (20 mol %), LiOtBu (1.1 equiv), DMI (0.66M), 50 °C. Isolated
yields are reported. bReaction performed at 2 mmol scale. cCuI (20
mol%) was used.
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the yields of reactions of MeOTs and MeI were 16−57% lower
than those of the reactions of PO(OMe)3.
A robustness test9 was also conducted to provide more
general information on the tolerance of the process for a series
of functional groups and potential limitation of PO(OMe)3 as
a methylating agent (see SI for detailed results). Reactions with
added unprotected amine, alcohol, or amide occurred in low to
moderate yield because methylation of the functional groups in
these additives was more facile than methylation of the
arylboronate, and competitive protodeboronation of the
arylboronate occurred. In contrast, high yields were observed
when reactions were run with analogous additives in which the
free N−H or O−H groups were protected by Boc, TIPS, or
TBS groups. Likewise, the methylation reactions conducted
with an added secondary dialkylamine, tertiary amine, allylic
ester, epoxide, pyridine, pyridine-1-oxide, nitrile, alkene,
ketone, imine, or aldehyde all gave the methylarene product
in high yield. The methylation reaction with a terminal alkyne
as additive gave only 7% yield, but the reaction with an internal
alkyne occurred in high yield.
Late-Stage Site Selective C−H Methylation of Bio-
logically Active Molecules. The current methods for the
methylation of unactivated C−H bonds are limited to N-
contained heteroaromatic compounds or arenes containing
directing groups. Published methods include Minisci reactions
with acetic acid as the methyl source,10 the addition of methyl
radicals to heteroarenes under both thermal and photoredox
conditions,11 and Pd- or Fe-catalyzed methylation of C−H
bonds in arenes containing a directing group.12
Due to the limited methods to realize the methylation of
inert C−H bonds,10−12 particularly an undirected methylation
of a C−H bond, we tested the combination of the methylation
of arylboronates with the borylation of aryl- and heteroaryl C−
H bonds.6 Four medicinally active compounds were chosen to
test this tandem process (Scheme 4). Clopidogrel,13 a
medication for heart disease and stroke known as Plavix,
underwent the one-pot, Ir-catalyzed borylation and copper-
catalyzed methylation with PO(OMe)3 to install a methyl
group selectively at the 2-position of the thiophene ring in high
yield (5a, 79%). A similar one-pot process enabled the late-
stage site-selective methylation of loratadine, sold as Claritin
for the treatment of allergies,14 in moderate yield (5b). The
benzothiazole-based heterocycle, PMX-610,15 which has
exhibited high antitumor activity in breast-cancer cell lines,
was modiﬁed by a stepwise borylation and methylation in 54%
overall yield (5c). Finally, this methylation also was tested for
the modiﬁcation of the hydrocarbyl natural product guai-
azulene which possesses anti-inﬂammatory and antioxidative
activity,16 providing methylated guaiazulene or CD3-guai-
azulene in 42% and 49% yield, respectively (5d, d3-5d).
Results with Reactions on 1000-Fold Larger Scale.
The feasibility of this coupling reaction for process scale was
assessed by conducting the reaction on a 200 mmol scale
(Scheme 5). This reaction aﬀorded 2a in 88% isolated yield in
92% purity after simple extraction. This yield is nearly identical
to that obtained with the same substrate on a smaller scale (0.2
mmol scale for 93% yield).
Mechanistic Studies. Uncovering the Role of PO(OMe)3
and Iodide. Methyl electrophiles typically react with organo-
metallic complexes by oxidative addition5a or SN2 substitu-
tion.5b To determine whether trimethylphosphate reacted by
one of these pathways, we conducted mechanistic studies.
The transmetalation of arylboronates to form arylcopper
complexes is well precedented.17 Thus, to understand how an
arylcopper complex would undergo methylation in this system,
we ﬁrst studied reactions of Mes-Cu with PO(OMe)3 and MeI
(Scheme 6a). The reaction of Mes-Cu with PO(OMe)3 gave
no product after 20 h, but the reaction with MeI aﬀorded Mes-
Me in 20% yield after 5 h at 40 °C and 58% yield after 42 h.
The analogous reactions also were conducted with the less
hindered PhCu, which is not isolable but can be generated in
situ.18 The reaction of this species with PO(OMe)3 gave no
detectable product after 10 min; in contrast, the reaction with
MeI occurred with a half-life of less than 2 min. These results
ﬁt our observation that the catalytic methylation reaction
proceeds only in the presence of halide (Table 1, entries 8 and
9). These results suggest that the combination of LiI and
trimethylphosphate generate MeI in the reaction system.
To assess this hypothesis, we studied the reaction of LiI with
PO(OMe)3 under conditions related to those of the catalytic
process (Scheme 6b). This reaction was too slow to be a step
of the catalytic process; only a trace of MeI was observed after
24 h at 40 °C. We considered that the Li+ of LiOtBu in the
catalytic system could act as a Lewis acid to increase the
electrophilicity of the methyl group of PO(OMe)3. Indeed, the
reaction of LiI with PO(OMe)3 in the presence of an
additional equimolar amount of LiBF4 released MeI much
faster than the reaction without LiBF4; 66% of MeI formed
Scheme 4. Late-Stage Site-Selective C−H Methylation of
Biologically Active Moleculesa
aSee SI for details.
Scheme 5. Reaction with 200 mmol of Arylboronate
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after 2 h. The same reaction at 50 °C reached equilibrium after
1.5 h to generate MeI in 80% yield, based on the iodide added.
Although this experiment showed that Li+ accelerates the
reaction, the lithium cations are associated with iodide and
alkoxide in the true reaction system. The Li+ added to the
system is not associated with a non-coordinating anion, such as
BF4
−, and if methyl iodide is formed, one might expect it to
react with the tert-butoxide in the system. Indeed, the reaction
of MeI with LiOtBu to give methyl tert-butyl ether occurs in
quantitative yield after 10 min at room temperature. To solve
this paradox about how Li+ could accelerate the formation of
MeI and why MeOtBu did not form from reaction of LiOtBu
and MeI in the catalytic reactions, we considered the role of
the arylboronic ester. LiOtBu reacted with the ArBpin reagent
to form Li[ArB(pin)OtBu], as determined by 11B NMR 19F
NMR spectroscopy of the reaction of these two components
alone. This borate was also the major form of the boron
reagent in the catalytic system, as determined by the similarity
of the 11B NMR and 19F NMR resonances of the catalytic
reaction to those of the borate generated separately (Scheme
6c).19 The lithium cation in this boronate complex is more
loosely bound than that in LiOtBu and can act as the Lewis
acid to catalyze formation of MeI. Moreover, the alkoxide unit
in this borate complex is much less nucleophilic than that in
LiOtBu and does not react with MeI.20
Kinetic Studies. To reveal the step that controls the overall
rate of the reaction, we conducted kinetic studies (Scheme 7).
The reaction was ﬁrst order in both [I−] and [PO(OMe)3]. In
contrast to most catalytic processes, the reaction was zero-
order in copper at the concentrations of the preparative
reactions. These data indicate that the generation of active
methyl electrophile is the rate-determining step. The
importance of the lithium cation generated from LiOtBu and
the ArBpin was supported by observing a ﬁrst-order depend-
ence of the rate on the concentration of both of these two
components. The importance of Li+ was also supported by the
separate observation of a ﬁrst-order dependence of the reaction
rate on LiBF4. These data imply that the reaction of the methyl
electrophile with copper and formation of the methylarene are
faster than generation of MeI. As described previously in this
section, the reaction of [I−] with [PO(OMe)3] occurs on the
time scale of hours at 40 °C, whereas the reaction of MeI with
PhCu occurs within minutes.
Proposed Mechanism. Based on these results, a mechanism
for the methylation of arylboronates with Cu(I) as catalyst and
iodide as co-catalyst is depicted in Scheme 8. In a rate-
determining step external to the catalytic cycle, iodide reacts
with PO(OMe)3 to release MeI. The slowly released MeI
rapidly reacts with the arylcopper intermediate generated from
the combination of CuI, LiOtBu, and ArBpin, either from
reaction of CuOtBu with ArBpin or reaction of CuI with
[ArBpin(OtBu)]−. The −OtBu does not react with MeI
because it is sequestered by the arylboronate, and the low
concentration of MeI ensures that the MeI in the system reacts
with the arylcopper species over many basic groups on the
arylboronate reagent.
■ CONCLUSION
In summary, we reveal an approach based on slow-release of
MeI for the methylation of arylboronates with trimethyl-
phosphate. This reagent is inexpensive and nontoxic, but it has
not been used previously as a source of a methyl group in
Scheme 6. Stoichiometric Reactions Potentially Occurring
in the Catalytic System
aReactivity comparison of MeI and PO(OMe)3 with ArCu.
bMeI
generation from PO(OMe)3 and LiI.
cReaction of 4-FPhBpin with
LiOtBu.
Scheme 7. Kinetic Order of the Methylation Reaction
Scheme 8. Proposed Reaction Mechanism
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coupling chemistry. By this unusual mechanism, the yields for
methylation with PO(OMe)3 are higher than those of the
more reactive methyl electrophiles MeOTs and MeI. Although
the mechanism involves a web of on-cycle and oﬀ-cycle steps
that make the reaction occur in high yield, it is amenable to
large scale and to the late-stage functionalization of
pharmaceutical intermediates. The reaction with 200 mmol
of arylboronate occurred the same yield as reactions with 0.2
mmol, and four medicinally active compounds were converted
selectively into the methyl analogues. The formation of MeI
from trimethylphosphate and LiI was rate limiting, and steps
on the catalytic cycle, including the reaction of MeI with the
arylcopper species, were fast. Overall, this process shows an
approach to using a methylating agent that does not react
directly with the metal center and is reminiscent of the use of
MeOH with HI for rhodium- and iridium-catalyzed synthesis
of acetic acid and acetic anhydride via the generation of MeI.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/jacs.8b10076.
Experimental details and procedures; spectra for all
unknown compounds (PDF)
■ AUTHOR INFORMATION
Corresponding Author
*jhartwig@berkeley.edu
ORCID
Gregory T. Whiteker: 0000-0002-9439-6696
John F. Hartwig: 0000-0002-4157-468X
Present Addresses
⊥The Dow Chemical Company, Midland, Michigan 48674,
United States.
∥BASF SE, Carl-Bosch-Strasse 38, Ludwigshafen am Rhein
67056, Germany.
Author Contributions
§Z.-T.H. and H.L. contributed equally.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
We thank Dow AgroSciences and the NIH (GM-115812) for
support of this work and the DAAD for a Postdoc Fellowship
to A.M.H.
■ REFERENCES
(1) (a) Bazzini, P.; Wermuth, C. G. Substituent Groups. The Practice
of Medicinal Chemistry, 3rd ed.; Academic Press: New York, 2008;
Chapter 20, pp 429−463. (b) Barreiro, E. J.; Kummerle, A. E.; Fraga,
C. A. Chem. Rev. 2011, 111, 5215−5246. (c) Schönherr, H.; Cernak,
T. Angew. Chem., Int. Ed. 2013, 52, 12256−12267.
(2) Anderson, K. E.; Stamler, D.; Davis, M. D.; Factor, S. A.; Hauser,
R. A.; Isojar̈vi, J.; Jarskog, L. F.; Jimenez-Shahed, J.; Kumar, R.;
McEvoy, J. P.; Ochudlo, S.; Ondo, W. G.; Fernandez, H. H. Lancet
Psychiatry 2017, 4, 595−604.
(3) Yan, G.; Borah, A. J.; Wang, L.; Yang, M. Adv. Synth. Catal. 2015,
357, 1333−1350.
(4) Hall, D. G. Boronic Acids: Preparation and Applications in Organic
Synthesis and Medicine; Wiley-VCH: Weinheim, 2005; pp 1 − 99.
(5) (a) Gooßen, L. Appl. Organomet. Chem. 2004, 18, 602−604.
(b) Yang, C. T.; Zhang, Z. Q.; Liu, Y. C.; Liu, L. Angew. Chem., Int.
Ed. 2011, 50, 3904−3907.
(6) (a) Mkhalid, I. A. I.; Barnard, J. H.; Marder, T. B.; Murphy, J.
M.; Hartwig, J. F. Chem. Rev. 2010, 110, 890−931. (b) Hartwig, J. F.
Acc. Chem. Res. 2012, 45, 864−873. (c) Xu, L.; Wang, G.; Zhang, S.;
Wang, H.; Wang, L.; Liu, L.; Jiao, J.; Li, P. Tetrahedron 2017, 73,
7123−7157.
(7) LD50 (oral, rats, mg/kg): MeI (78), MeOTs (341), SO2(OMe)2
(205), PO(OMe)3 (2000).
(8) (a) Jones, F. W.; Osborne, G. O.; Sutherland, G. J.; Topsom, R.
D.; Vaughan, J. Chem. Commun. 1966, 18−19. (b) Duclos, M.-C.;
Herbinski, A.; Mora, A.-S.; Metay, E.; Lemaire, M. ChemSusChem
2018, 11, 547−551.
(9) Collins, K. D.; Glorius, F. Nat. Chem. 2013, 5, 597−601.
(10) Minisci, F.; Bernardi, R.; Bertini, F.; Galli, R.; Perchinummo,
M. Tetrahedron 1971, 27, 3575−3579.
(11) (a) Jin, J.; MacMillan, D. W. Nature 2015, 525, 87−90. (b) Liu,
W.; Yang, X.; Zhou, Z.-Z.; Li, C.-J. Chem. 2017, 2, 688−702. (c) Gui,
J.; Zhou, Q.; Pan, C. M.; Yabe, Y.; Burns, A. C.; Collins, M. R.;
Ornelas, M. A.; Ishihara, Y.; Baran, P. S. J. Am. Chem. Soc. 2014, 136,
4853−4856.
(12) (a) Giri, R.; Maugel, N.; Li, J. J.; Wang, D. H.; Breazzano, S. P.;
Saunders, L. B.; Yu, J. Q. J. Am. Chem. Soc. 2007, 129, 3510−3511.
(b) Shang, R.; Ilies, L.; Nakamura, E. J. Am. Chem. Soc. 2016, 138,
10132−10135.
(13) Sashikanth, S.; Raju, V.; Somaiah, S.; Rao, P. S.; Reddy, K. V.
Synthesis 2013, 45, 621−624.
(14) Wang, Y.; Wang, J.; Lin, Y.; Si-Ma, L.-F.; Wang, D.-H.; Chen,
L.- G.; Liu, D.-K. Bioorg. Med. Chem. Lett. 2011, 21, 4454−4456.
(15) Mondal, J.; Sreejith, S.; Borah, P.; Zhao, Y. ACS Sustainable
Chem. Eng. 2014, 2, 934−941.
(16) Kourounakis, A. P.; Rekka, E. A.; Kourounakis, P. N. J. Pharm.
Pharmacol. 1997, 49, 938−942.
(17) (a) Whittaker, A. M.; Rucker, R. P.; Lalic, G. Org. Lett. 2010,
12, 3216−3218. (b) Ohishi, T.; Nishiura, M.; Hou, Z. Angew. Chem.,
Int. Ed. 2008, 47, 5792−5795. (c) Dang, L.; Lin, Z.; Marder, T. B.
Organometallics 2010, 29, 917−927. (d) Gurung, S. K.; Thapa, S.;
Kafle, A.; Dickie, D. A.; Giri, R. Org. Lett. 2014, 16, 1264−1267.
(18) Kobayashi, Y.; Ikoma, A. Synlett 2014, 25, 1150−1154.
(19) Procter, R. J.; Dunsford, J. J.; Rushworth, P. J.; Hulcoop, D. G.;
Layfield, R. A.; Ingleson, M. J. Chem. - Eur. J. 2017, 23, 15889−15893.
(20) The reaction of o-tol-Bpin(OtBu) generated in situ with an
equimolar amount of MeI at 40 °C led to 38% conversion of the o-tol-
Bpin(OtBu) after 1 h, which is signiﬁcantly slower than the reaction of
ArCu with MeI (half-life < 2 min).
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.8b10076
J. Am. Chem. Soc. 2018, 140, 17197−17202
17202
